BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6092443)

  • 21. Glucagonoma presenting as morbid obesity.
    Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
    J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagonoma syndrome: a case report.
    Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glucagonoma syndrome.
    Shupack JL; Berczeller PH; Stevens DM
    J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of pancreatic glucagonoma].
    Simonenko VB; Dulin PA; Beliaev LB; Makanin MA; Dem'ianenko AV; Zykova AA; Zhuravleva SI; Kolesnikova VN
    Klin Med (Mosk); 2007; 85(8):67-70. PubMed ID: 17926496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucagonoma syndrome].
    Coindre MC; Fétissoff F; Lemaire M; Garrigue MA; Lorette G
    Ann Dermatol Venereol; 1985; 112(11):911-4. PubMed ID: 3004309
    [No Abstract]   [Full Text] [Related]  

  • 27. [The glucagonomas (author's transl)].
    Luyckx AS; Lefebvre PJ
    Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glucagonoma syndrome. Clinico-therapeutic data relative to personal experience and review of the literature].
    Biliotti GC; Vestrini G; Tonelli P; Vallecchi C
    Minerva Chir; 1989 Jan; 44(1-2):163-72. PubMed ID: 2540454
    [No Abstract]   [Full Text] [Related]  

  • 29. A serpiginous eruption.
    Esdaile BA; Hollowood K; Burge S
    Arch Dermatol; 2012 Mar; 148(3):385-90. PubMed ID: 22431782
    [No Abstract]   [Full Text] [Related]  

  • 30. Necrolytic migratory erythema due to glucagonoma.
    Michels G; Nierhoff D; Steffen HM
    Clin Gastroenterol Hepatol; 2010 Aug; 8(8):A18. PubMed ID: 20060072
    [No Abstract]   [Full Text] [Related]  

  • 31. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
    Mullans EA; Cohen PR
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 33. [The glucagonoma syndrome. Apropos of a case without diabetes. Review of the literature].
    Pizzi M; Weiller M; Lansman V; Scheiner C; Dor AM; Lebreuil G
    Arch Anat Cytol Pathol; 1982; 30(5-6):257-64. PubMed ID: 6301386
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
    Ditty JF; Lang PG
    South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucagonoma syndrome with atypical necrolytic migratory erythema.
    He S; Zeng W; Geng S; Jia J
    Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The glucagonoma syndrome].
    Levitskaia ZI; Balabolkin MI; Gordina AA; Goriainova II; Tatochenko KV
    Sov Med; 1985; (9):120-3. PubMed ID: 2999999
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.
    Gross TL; O'Brien TD; Davies AP; Long RE
    J Am Vet Med Assoc; 1990 Dec; 197(12):1619-22. PubMed ID: 2276959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.